StonvexLoading…
StonvexStonvexStonvexCore line items from SNX's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Q2 2026 (Est.) Expected 2026-06-22 | Q1 2026 2026-02-28 | Annual 2025 2025-11-30 | Q3 2025 2025-08-31 | Q2 2025 2025-05-31 |
|---|---|---|---|---|---|
Revenue | $16.87B | $17.16B | $62.51B | $45.13B | $29.48B |
Operating Income | Not available | $489.36M | $1.41B | $1.02B | $632.60M |
Net Income | Not available | $326.92M | $827.66M | $579.25M | $352.46M |
EPS (Diluted) | $4.13 | $4.04 | $9.95 | $6.92 | $4.19 |
Total Assets | Not available | $35.08B | $34.25B | $31.68B | $30.51B |
Total Liabilities | Not available | $26.30B | $25.80B | $23.23B | $22.17B |
Cash & Equivalents | Not available | $1.56B | $2.44B | $874.35M | $767.10M |
Free Cash Flow OCF − CapEx | Not available | $-929.01M | $1.39B | $-32.66M | $-246.58M |
Shares Outstanding | Not available | 80.18M | 82.43M | 82.93M | 83.45M |